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A
hallmark of parasitic helminths is their ability to persist for years within their host despite constant pressure from the immune system. To achieve this, helminths subvert the host immune system by hijacking the regulatory networks that keep it in check (1, 2) . Foxp3 ϩ regulatory T (Treg) cells are a principal component of this network and are potent suppressors of immunity (3) . As such, they are a key cell type targeted by helminths in defense against attack from the host immune system (4) . The expansion and activation of Foxp3 ϩ Treg cells occur within the first week of both filarial (5-7) and intestinal (8-10) nematode infections. This early induction of Foxp3 ϩ Treg cells impairs late-stage effector immunity, to the detriment of host protection (7, 8, 11) . Thus, nematode infections bias early immune responses toward regulation to benefit their own survival.
Schistosoma mansoni is a blood-dwelling trematode parasite that is the etiological agent of the tropical disease hepatic schistosomiasis (12) . Infective S. mansoni cercariae penetrate the skin of their host and migrate via the circulation, transiting the lungs to reside as adults in the mesenteric veins, where they mate and lay eggs (12) . Infections of this type are typically chronic, and the liver fibrosis, portal hypertension, and intestinal bleeding that characterize the disease arise as a consequence of the host immune response to the parasite's eggs (13) . During the patent, egg-producing phase of disease (week 5 onwards), Foxp3
ϩ Treg cells are activated and suppress Th2 responses, controlling immunopathology in the liver (14) (15) (16) and in the colon (17) . However, little is known of their role and induction in the early larval lung transit phase of disease.
Although the protective immune mechanisms underlying resistance to S. mansoni larvae in primary infections are poorly understood, during challenge infections, it has been shown that immune responses directed against lung-stage S. mansoni larvae are required for protection (18, 19) . Protective immunity is significantly elevated in the absence of the suppressive cytokine interleukin 10 (IL-10) (20, 21) , suggesting that immunity to S. mansoni larvae in the lung is inhibited by immune regulation. IL-6 deficiency leads to enhanced Th2 responses and increased protective immunity to lung-stage S. mansoni larvae (22) , and the absence of IL-6 can impair Foxp3 ϩ Treg cell function during Heligmosomoides polygyrus infection, resulting in increased Th2 effector responses and parasite killing (23) . These data suggest a role for Foxp3 ϩ Treg cells in the suppression of protective Th2 responses to S. mansoni larvae in the lungs, potentially via IL-10.
We hypothesized that larval S. mansoni parasites rapidly co-opt Foxp3 ϩ Treg cell function at an early stage of infection to benefit their own survival, inducing the activation and expansion of 
MATERIALS AND METHODS
Animals, infections, and parasites. Female C57BL/6 mice were bred inhouse and maintained under specific-pathogen-free conditions at the University of Edinburgh. Mice were used at 6 to 8 weeks of age, and all animal work was conducted in accordance with the Animals (Scientific Procedures) Act 1986. Biomphalaria glabrata snails infected with S. mansoni parasites were obtained from F. Lewis (Biomedical Research Institute, Rockville, MD). C57BL/6 mice were infected percutaneously with 70 S. mansoni cercariae. S. mansoni parasite numbers were quantified by portal perfusion at weeks 2 and 3 to confirm successful infections. A count of 10.4 Ϯ 5.4 (mean Ϯ standard deviation) parasites was recovered at week 2, and a count of 10.6 Ϯ 7.9 was recovered at week 3.
Cell purifications and in vitro stimulation. The lungs, lung-draining thoracic lymph nodes (tLN), inguinal lymph nodes (iLN) draining the abdominal skin, and spleens were collected. The tLN, iLN, and spleens were dissociated to obtain a single-cell suspension in RPMI 1640 (Invitrogen) supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, and 5% fetal calf serum (FCS). To isolate lung lymphocytes, lung lobes were dissociated in RPMI 1640 with 5% FCS (Invitrogen), 100 U/ml penicillin-100 g/ml streptomycin, and 2 mM L-glutamine and then incubated in 250 g/ml collagenase D (Roche) and 10 g/ml DNase (Roche) for 30 min at 37°C before being passed through a 70-m nylon mesh. Erythrocytes in spleen and lung preparations were lysed using red blood cell lysis buffer (Sigma). For measurement of intracellular cytokines, cells were stimulated for 4 h with 0.5 g/ml phorbol myristate acetate and 1 g/ml ionomycin, with 10 g/ml brefeldin A added for the final 2 h (Sigma-Aldrich).
Flow cytometry. The following antibodies were used: Alexa Fluor 700-conjugated anti-CD4 antibody (RM4-5; BD Bioscience), fluorescein isothiocyanate-conjugated or allophycocyanin-conjugated anti-Foxp3 antibody (FJK-16S; eBioscience), phycoerythrin-conjugated anti-Helios antibody (22F6; Biolegend), phycoerythrin-conjugated anti-CD25 antibody (PC61 5.3; Invitrogen), phycoerythrin-conjugated anti-IL-4 antibody (11B11), Alexa Fluor 647-conjugated anti-IL-13 antibody (ebio13A; eBioscience), Pacific blue-conjugated anti-T cell receptor ␤ (TCR-␤) antibody (H57-597; Biolegend), allophycocyanin-conjugated anti-IL-10 antibody (JES5-16E3; eBioscience), and fluorescein isothiocyanate-conjugated anti-gamma interferon (IFN-␥) antibody (XMG1.2; BD Bioscience). Nonspecific binding was blocked with 4 g of rat IgG per 1 ϫ 10 6 cells. Intracellular staining for Foxp3 and Helios was performed using a Foxp3-staining buffer kit (eBioscience). For intracellular cytokine staining, dead cells were excluded using the Live/ Dead aqua dead cell stain kit (Molecular Probes), and cells were fixed and permeabilized using the BD Cytofix/Cytoperm kit. Flow cytometry was performed using a FACSCanto 2 or an LSR 2 (BD Biosciences), running FACSDiva software (BD Biosciences). Analysis was performed using FlowJo (Tree Star).
Statistics. Statistical analysis was performed using JMP (SAS) version 8. Parametric analysis of combined data from multiple-repeat experiments or experiments containing more than two groups was performed using analysis of variance (ANOVA), followed by the least squares means (LSM) Student's t test.
RESULTS

Transit of S. mansoni larvae through the lung does not cause expansion of Foxp3
؉ Treg cells. The rapid recruitment and activation of Foxp3 ϩ Treg cells is a feature of infections with parasitic nematodes (7-9, 14, 26) . However, the role of Foxp3 ϩ Treg cells in immunity to early-stage S. mansoni infection is unclear. To address whether Foxp3 ϩ Treg cell responses are evoked during the initial stages of S. mansoni infection, as the larvae transit from the skin through the lungs to the hepatic portal and mesenteric vasculature, we infected C57BL/6 mice with 70 S. mansoni cercariae and measured Foxp3 responses in the iLN (draining the skin site of inoculation), lungs, tLN (draining the lungs), and spleen at days 7, 14, and 21 postinfection (p.i.). Throughout this period, there was no difference in the percentages of CD4 ϩ T cells expressing Foxp3 in the lungs in naive and S. mansoni-infected wild-type mice ( Fig. 1A and B). Although there was a trend for an increase in the absolute numbers of Foxp3 ϩ cells in the lungs of infected mice, this did not reach statistical significance (Fig. 1C) . Similarly, the percentages and numbers of Foxp3 ϩ CD4 ϩ T cells remained unchanged by S. mansoni infection in the tLN, iLN, and spleen ( ϩ Treg cells were activated by S. mansoni larvae, we measured the expression of CD25, Foxp3, and Helios on Foxp3 ϩ T cells in the lungs, tLN, iLN, and spleen during the first 3 weeks of S. mansoni infection ( Fig. 2A) . While Helios expression was originally reported to distinguish thymic Treg cells from peripheral Treg cells (27) , more recent evidence suggests that it is a marker of Treg cell activation (28) . In contrast to the egg phase of infection, when Foxp3 ϩ Treg cells actively control pathology (14) (15) (16) (17) , there was no significant increase in the mean fluorescence intensity (MFI) of CD25 expression on Foxp3 ϩ Treg cells in the lungs or at any other site measured during early-stage S. mansoni infection (Fig. 2B) . Similarly, there was no increase in Foxp3 MFI iLN, or spleen during the first 3 weeks of infection (Fig.  2C ). The expression of the transcription factor Helios also remained constant following infection (Fig. 2D ). Taken together, these data suggest that the migration of S. mansoni larvae through the lungs does not significantly alter the activation state of Foxp3 (20) and prevents resistance to reinfection (21) . To test whether Foxp3 ϩ Treg cells produce IL-10 in response to the migration of S. mansoni larvae, we quantified the expression of Foxp3 and IL-10 by flow cytometry of CD4 ϩ T cells at days 14 and 21 p.i. (Fig. 3A ). Due to low lung cell numbers, our analysis was restricted to the tLN and spleen. There was no increase in the percentage of CD4 ϩ
Foxp3
ϩ Treg cells expressing IL-10 upon infection in either the tLN or spleen (Fig. 3B and C) . In contrast to the Foxp3 ϩ Treg cell population, at day 21 p.i., there was a significant increase in the percentage of Foxp3 Ϫ CD4 ϩ T cells producing IL-10 in both the tLN and spleen ( Fig. 3D and E mune responses during early schistosome infection remains controversial. While vaccine studies originally indicated that the initial immune response to invading S. mansoni larvae is primarily Th1 (18, 29) , more recent evidence has shown that Th2 immune responses are also induced at this stage of infection (30) . To gain a further understanding of the character of the initial immune response directed against S. mansoni larvae, we measured CD4 ϩ T cell IFN-␥ and IL-4 production at days 7, 14, and 21 p.i. in the iLN and spleen and at days 14 and 21 p.i. in the tLN by intracellular cytokine staining. Due to limited cell numbers, we were unable to perform intracellular cytokine staining at day 7 p.i. in the tLN. In agreement with previous data (31), we observed significantly increased CD4 ϩ T cell IFN-␥ production in the spleen at day 21 p.i. (Fig. 4A) . However, IFN-␥ was not detected at earlier time points (days 7 and 14) in the spleen or at any time p.i. in the tLN and iLN. In contrast, IL-4-expressing T cells increased significantly by day 7 p.i. in the spleen and iLN and remained elevated through days 14 and 21 (Fig. 4B) . Similarly, IL-4-expressing T cells increased sig- nificantly in the tLN at days 14 and 21 p.i. (Fig. 4B) . This, along with the IL-10 data, indicates that the lack of a Foxp3 ϩ Treg cell response is not due to a failure to mount an immune response toward the larvae and that, while a mixed Th1 and Th2 response is mounted toward S. mansoni larvae, IL-4-producing Th2 cells predominate during this early period of infection. CD4 ؉ T cell-derived IL-10 is produced by IL-4 ؉ Th2 cells in the early phase of infection. Evidence suggests that during the egg phase of S. mansoni infection, the dominant cellular sources of suppressive IL-10 are either Th2 or Tr1 cells (14, 21, 32, 33) . To test the contribution of these cells to the IL-10 produced in the early phase of infection, we measured the proportions of CD4 ϩ
Ϫ IL-10 ϩ T cells coexpressing IFN-␥ and IL-4. The largest population of IL-10 secretors was IL-4 Ϫ IFN-␥ Ϫ in both naive and infected mice (Fig. 5A and B) . However, the proportion of these cells was significantly reduced upon S. mansoni infection, indicating that S. mansoni infection does not stimulate IL- (Fig. 5C ) and no change in the proportions of IL-4 Ϫ IFN-␥ ϩ cells (Fig. 5D) . Similarly, there was an increase in the total numbers of CD4 ϩ Foxp3 Ϫ IL-10 ϩ IL-4 ϩ IFN-␥ Ϫ T cells but no change in the total numbers of CD4 ϩ Foxp3 Ϫ IL-10
cells (data not shown). These data indicate that IL-4
ϩ Th2 cells increase their production of IL-10 in the LN and spleen during early S. mansoni infection.
DISCUSSION
Schistosomiasis is one of the most important neglected tropical diseases, with over 200 million people afflicted in many low-and middle-income countries (34) . Chronic infection has been associated with increased immunoregulatory mechanisms, including the expansion of regulatory T cells (35, 36) and the dampening of allergic and autoimmune responses to bystander antigens (37) (38) (39) (40) . Rapid expansion of Foxp3 ϩ Treg cells has been clearly shown to occur in the early phase of several helminth infections, such as nematode parasites in mouse models, resulting in impaired protective immunity. Foxp3 ϩ Treg cells rapidly become activated and increase in number during the larval stages of Litomosoides sigmodontis infection, and ablation of CD25 ϩ Treg cells before or during infection enhances parasite killing (7, 25, 41) . Similarly, early expansion of Foxp3 ϩ Treg cells that inhibit type 2 immunity is observed during intestinal nematode infections with H. polygyrus, Trichuris muris, and Strongyloides ratti (8, 9, 11, 24, 42) . In
S. ratti and T. muris infections, Foxp3
ϩ Treg cells act very early, and protective immunity can only be restored if they are depleted prior to day 4 or day 9 of infection, respectively (8, 11, 24) . Hence, we investigated whether S. mansoni parasites would also induce Foxp3 ϩ Treg cell expansion during the early stages of infection when the parasites transit the lungs. However, our study demonstrates that, in contrast to the response to other helminths, Foxp3
ϩ Treg cells do not expand, upregulate activation markers, or produce IL-10 during the early larval stages of S. mansoni infection in C57BL/6 mice.
Altogether, this suggests that migrating S. mansoni larvae do not initiate a Foxp3
ϩ Treg cell response in C57BL/6 mice and that co-option of Treg cell function is not a survival strategy used by S. mansoni parasites to avoid host immune attack. In keeping with this, depletion of CD25 ϩ T cells immediately prior to S. mansoni infection of C57BL/6 mice does not affect the parasite burden (15) ϩ Treg cell responses are seen in response to filarial nematodes (7) and Foxp3 ϩ Treg cell depletion promotes resistance to T. muris (11) . Thus, while it is likely that the lack of Foxp3 ϩ Treg cell activity in early S. mansoni infection is a general feature of infection, there remains the possibility that in other, as yet untested strains, Foxp3
ϩ Treg cell activation and expansion may occur.
S. mansoni employs a number of strategies for defense against host immunity, such that it may not need to utilize Foxp3 ϩ Treg cells for this purpose. For example, S. mansoni parasites have acquired the ability to hide from the host's immune system, secreting a membranocalyx that surrounds them and shields vulnerable surface proteins from immune recognition (45) . Embedded in the membranocalyx are blood group antigens and host major histocompatibility complex (MHC) molecules that disguise the parasites from immune attack (46, 47) .
At the cellular level, widespread interactions occur between schistosomes and host immune populations. Thus, larval secretions generate a population of antigen-presenting cells that prime CD4 ϩ T cells to produce high levels of the suppressive cytokine IL-10 (48). In addition, IL-10 from a range of different cell types, including regulatory B cells and innate effector cells, is important in chronic schistosomiasis (49) (50) (51) (52) , but to date, no evidence of their activation in the early larval stage of infection has been obtained.
In contrast, early CD4 ϩ T cell IL-10 expression is observed during vaccination settings, in which radiation-attenuated S. mansoni larvae stimulate the production of IL-10, which suppresses the development of a robust Th1 response in the skindraining lymph nodes (53, 54) . The induction of Th1 cells in the skin-draining lymph nodes is required for their recruitment to the lung (18) , where they initiate the formation of inflammatory foci which block the passage of transiting larvae (19) , and in the absence of IL-10, protective immunity to S. mansoni infection is enhanced (20) . Similarly, IL-10 prevents the development of protective memory responses to S. mansoni larvae (21) . This suggests that the induction of IL-10 is a key survival strategy used by S. mansoni larvae for evasion of host immunity.
While IL-10 impairs protective immunity during the early stages of S. mansoni infection (20) , during the egg phase of disease, IL-10 acts primarily to suppress immunopathology (55) . Although Foxp3
ϩ Treg cells are a major source of IL-10 at the site of H. polygyrus infection (10), evidence suggests that the majority of T cell-derived IL-10 produced during the patent egg phase of S. mansoni infection comes from Foxp3 Ϫ Th2 cells (14, 21, 33) , although there is some evidence for the induction of Tr1 cells (32) . Similarly, CD4
ϩ Foxp3 Ϫ T cells are the main T cell source of IL-10 in other filarial and intestinal helminth infections (56) (57) (58) . We observed that the largest population of IL-10-producing CD4 ϩ T cells in both naive and infected mice was negative for Foxp3, IL-4, and IFN-␥. However, during early S. mansoni infection, the proportion of these cells declined and a population of IL-10 ϩ Foxp3 Ϫ CD4 ϩ IL-4 ϩ IFN-␥ Ϫ Th2 cells emerged. This suggests that Th2 cells are the main T cell population stimulated to produce IL-10 during both the lung and egg stage of S. mansoni infection. Therefore, the lack of an early lung-stage Foxp3 ϩ Treg cell response could reflect the fact that non-Treg, Th2 cell-derived IL-10 plays a suppressive role, and S. mansoni does not need to elicit a Foxp3 ϩ Treg cell response to evade immune attack.
In summary, this work has demonstrated that the character of the initial immune response invoked by S. mansoni parasites in C57BL/6 mice contrasts with the responses to other parasitic helminth infections, which promote rapid Foxp3 ϩ Treg cell responses. Thus, S. mansoni larvae do not cause the activation of, expansion of, or IL-10 production by Foxp3 ϩ Treg cells during the early migratory phase of infection. This suggests that Foxp3 ϩ Treg cells do not play a major role in regulating immunity to schistosome larval stages and that co-option of Treg cell function is not a survival mechanism employed by this trematode parasite.
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